Structure of trans-resveratrol in complex with the cardiac regulatory protein troponin C

Biochemistry

Volumn 50, Issue 8, 2011, Pages 1309-1320

  Pineda Sanabria, Sandra E ^a   Robertson, Ian M ^a   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PARTNERS; C-DOMAIN; CALCIUM BINDING PROTEINS; CARDIAC TROPONIN; CARDIO-VASCULAR DISEASE; COLLINS; CONFORMATIONAL CHANGE; DEATH RATES; GUINEA PIGS; HEART CONTRACTION; HEART DISEASE; HYDROPHOBIC POCKETS; MACLEOD; MECHANISM OF ACTION; MYOCYTES; PROTEIN COMPLEXES; REGULATORY PROTEIN; TRANS-RESVERATROL; TROPONIN; TROPONIN C; TROPONIN I;

CARDIOLOGY; CESIUM; MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POPULATION STATISTICS; PROTEINS; WINE;

HEART;

BINDING PROTEIN; RESVERATROL; TROPONIN C; TROPONIN I;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG MECHANISM; DRUG PROTEIN BINDING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN;

CARDIOTONIC AGENTS; DEUTERIUM OXIDE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MYOCARDIUM; PROTEIN BINDING; PROTEIN CONFORMATION; STILBENES; TROPONIN C;

CAVIA;

EID: 79951924666     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi101985j     Document Type: Article

References (95)

1. Sia, S. K., Li, M. X., Spyracopoulos, L., Gagne, S. M., Liu, W., Putkey, J. A., and Sykes, B. D. (1997) Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain J. Biol. Chem. 272, 18216-18221
2. 2+-saturated form Nature 424, 35-41
3. Spyracopoulos, L., Li, M. X., Sia, S. K., Gagne, S. M., Chandra, M., Solaro, R. J., and Sykes, B. D. (1997) Calcium-induced structural transition in the regulatory domain of human cardiac troponin C Biochemistry 36, 12138-12146
4. Li, M. X., Spyracopoulos, L., and Sykes, B. D. (1999) Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C Biochemistry 38, 8289-8298
5. 2+-dependent regulation of muscle contraction J. Mol. Biol. 271, 728-750
6. Li, M. X., Wang, X., and Sykes, B. D. (2004) Structural based insights into the role of troponin in cardiac muscle pathophysiology J. Muscle Res. Cell Motil. 25, 559-579
7. Kobayashi, T., Jin, L., and de Tombe, P. P. (2008) Cardiac thin filament regulation Pfluegers Arch. 457, 37-46
8. 2+ sensitizers: Update 2001 Cardiovasc. Drugs Ther. 15, 397-403 (Pubitemid 34098510)
9. Kleerekoper, Q., Liu, W., Choi, D., and Putkey, J. A. (1998) Identification of binding sites for bepridil and trifluoperazine on cardiac troponin C J. Biol. Chem. 273, 8153-8160
10. Li, Y., Love, M. L., Putkey, J. A., and Cohen, C. (2000) Bepridil opens the regulatory N-terminal lobe of cardiac troponin C Proc. Natl. Acad. Sci. U.S.A. 97, 5140-5145
11. Haikala, H., Kaivola, J., Nissinen, E., Wall, P., Levijoki, J., and Linden, I. B. (1995) Cardiac Troponin-C as a Target Protein for a Novel Calcium Sensitizing Drug, Levosimendan J. Mol. Cell. Cardiol. 27, 1859-1866
12. Haikala, H., Nissinen, E., Etemadzadeh, E., Levijoki, J., and Linden, I. B. (1995) Troponin C-Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation J. Cardiovasc. Pharmacol. 25, 794-801
13. Haikala, H., Nissinen, E., Etemadzadeh, E., Linden, I. B., and Pohto, P. (1992) Levosimendan Increases Calcium Sensitivity without Enhancing Myosin Atpase Activity and Impairing Relaxation J. Mol. Cell. Cardiol. 24, S97
14. 2+ sensitizing drug EMD 57033 J. Biol. Chem. 276, 25456-25466
15. Pan, B. S. and Johnson, R. G. (1996) Interaction of cardiotonic thiadiazinone derivatives with cardiac troponin C J. Biol. Chem. 271, 817-823
16. Kleerekoper, Q. and Putkey, J. A. (1999) Drug binding to cardiac troponin C J. Biol. Chem. 274, 23932-23939
17. 2+ sensitivity of cardiac and skeletal muscle Pfluegers Arch. 456, 787-800
18. Tadano, N., Du, C. K., Yumoto, F., Morimoto, S., Ohta, M., Xie, M. F., Nagata, K., Zhan, D. Y., Lu, Q. W., Miwa, Y., Takahashi-Yanaga, F., Tanokura, M., Ohtsuki, I., and Sasaguri, T. (2010) Biological actions of green tea catechins on cardiac troponin C Br. J. Pharmacol. 161, 1034-1043
19. Robertson, I. M., Li, M. X., and Sykes, B. D. (2009) Solution Structure of Human Cardiac Troponin C in Complex with the Green Tea Polyphenol, (-)-Epigallocatechin 3-Gallate J. Biol. Chem. 284, 23012-23023
20. Renaud, S. and Delorgeril, M. (1992) Wine, Alcohol, Platelets, and the French Paradox for Coronary Heart Disease Lancet 339, 1523-1526
21. Langcake, P. and Pryce, R. J. (1976) Production of Resveratrol by Vitis-Vinifera and Other Members of Vitaceae as a Response to Infection or Injury Physiol. Plant Pathol. 9, 77-86
22. Siemann, E. H. and Creasy, L. L. (1992) Concentration of the Phytoalexin Resveratrol in Wine Am. J. Enol. Vitic. 43, 49-52
23. Das, D. K., Mukherjee, S., and Ray, D. (2010) Resveratrol and red wine, healthy heart and longevity Heart Failure Rev. 15, 467-477
24. Lekli, I., Ray, D., and Das, D. K. (2010) Longevity nutrients resveratrol, wines and grapes Genes Nutr. 5, 55-60
25. Nichols, J. A. and Katiyar, S. K. (2010) Skin photoprotection by natural polyphenols: Anti-inflammatory, antioxidant and DNA repair mechanisms Arch. Dermatol. Res. 302, 71-83
26. Sun, A. Y., Wang, Q., Simonyi, A., and Sun, G. Y. (2010) Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases Mol. Neurobiol. 41, 375-383
27. Jang, M. S., Cai, E. N., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275, 218-220
28. Holme, A. L. and Pervaiz, S. (2007) Resveratrol in cell fate decisions J. Bioenerg. Biomembr. 39, 59-63
29. Das, D. K. and Maulik, N. (2006) Red wine and heart: A cardioprotective journey from grape to resveratrol Alcohol.: Clin. Exp. Res. 30, 84a
30. Ray, P. S., Maulik, G., Cordis, G. A., Bertelli, A. A. E., Bertelli, A., and Das, D. K. (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury Free Radical Biol. Med. 27, 160-169
31. Liew, R., Stagg, M. A., MacLeod, K. T., and Collins, P. (2005) The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes Eur. J. Pharmacol. 519, 1-8
32. Bertini, I., Fragai, M., Giachetti, A., Luchinat, C., Maletta, M., Parigi, G., and Yeo, K. J. (2005) Combining in silico tools and NMR data to validate protein-ligand structural models: Application to matrix metalloproteinases J. Med. Chem. 48, 7544-7559
33. Cioffi, M., Hunter, C. A., Packer, M. J., and Spitaleri, A. (2008) Determination of protein-ligand binding modes using complexation-induced changes in H-1 NMR chemical shift J. Med. Chem. 51, 2512-2517
34. Krishnamoorthy, J., Yu, V. C. K., and Mok, Y. K. (2010) Auto-FACE: An NMR Based Binding Site Mapping Program for Fast Chemical Exchange Protein-Ligand Systems PLoS One 5 e8943
35. Pintacuda, G., John, M., Su, X. C., and Otting, G. (2007) NMR structure determination of protein-ligand complexes by lanthanide labeling Acc. Chem. Res. 40, 206-212
36. Hoffman, R. M. B. and Sykes, B. D. (2009) Structure of the Inhibitor W7 Bound to the Regulatory Domain of Cardiac Troponin C Biochemistry 48, 5541-5552
37. Chandra, M., Dong, W. J., Pan, B. S., Cheung, H. C., and Solaro, R. J. (1997) Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C Biochemistry 36, 13305-13311
38. Li, M. X., Gagne, S. M., Tsuda, S., Kay, C. M., Smillie, L. B., and Sykes, B. D. (1995) Calcium-Binding to the Regulatory N-Domain of Skeletal-Muscle Troponin-C Occurs in a Stepwise Manner Biochemistry 34, 8330-8340
39. Lykkesfeldt, J. (2000) Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: Reliable reduction with tris[2-carboxyethyl] phosphine hydrochloride Anal. Biochem. 282, 89-93 (Pubitemid 30409428)
40. Gemmecker, G., Olejniczak, E. T., and Fesik, S. W. (1992) An Improved Method for Selectively Observing Protons Attached to C-12 in the Presence of H-1-C-13 Spin Pairs J. Magn. Reson. 96, 199-204
41. Ikura, M. and Bax, A. (1992) Isotope-Filtered 2D NMR of a Protein Peptide Complex: Study of a Skeletal-Muscle Myosin Light Chain Kinase Fragment Bound to Calmodulin J. Am. Chem. Soc. 114, 2433-2440
42. Stuart, A. C., Borzilleri, K. A., Withka, J. M., and Palmer, A. G. (1999) Compensating for variations in H-1-C-13 scalar coupling constants in isotope-filtered NMR experiments J. Am. Chem. Soc. 121, 5346-5347
43. Lee, W., Revington, M. J., Arrowsmith, C., and Kay, L. E. (1994) A Pulsed-Field Gradient Isotope-Filtered 3D C-13 HMQC-NOESY Experiment for Extracting Intermolecular NOE Contacts in Molecular Complexes FEBS Lett. 350, 87-90
44. Robertson, I. M., Spyracopoulos, L., and Sykes, B. D. (2009) The Evaluation of Isotope Editing and Filtering for Protein-Ligand Interaction Elucidation by NMR Biophysics and the Challenges of Emerging Threats, 101-119
45. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) Nmrpipe: A Multidimensional Spectral Processing System Based on Unix Pipes J. Biomol. NMR 6, 277-293
46. Johnson, B. A. and Blevins, R. A. (1994) Nmr View: A Computer Program for the Visualization and Analysis of NMR Data J. Biomol. NMR 4, 603-614
47. Lin, X., Krudy, G. A., Howarth, J., Brito, R. M. M., Rosevear, P. R., and Putkey, J. A. (1994) Assignment and Calcium-Dependence of Methionyl ε-C and ε-H Resonances in Cardiac Troponin-C Biochemistry 33, 14434-14442
48. Schuttelkopf, A. W. and van Aalten, D. M. F. (2004) PRODRG: A tool for high-throughput crystallography of protein-ligand complexes Acta Crystallogr. D60, 1355-1363
49. Kleywegt, G. J., Zou, J. Y., Kjeldgaard, M., Jones, T. A., and Around, O. (2001) International Tables for Crystallography, Volume F. Crystallography of Biological Macromolecules (Rossmann, M. G. and Arnold, E., Eds.) pp 353 - 356, 366-367, Kluwer Academic Publishers, Dordrecht, The Netherlands.
50. Schwieters, C. D., Kuszewski, J. J., Tjandra, N., and Clore, G. M. (2003) The Xplor-NIH NMR molecular structure determination package J. Magn. Reson. 160, 65-73
51. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Montgomery, J. A., Jr., Vreven, T., Kudin, K. N., Burant, J. C., Millam, J. M., Iyengar, S. S., Tomasi, J., Barone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, N., Petersson, G. A., Nakatsuji, H., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Klene, M., Li, X., Knox, J. E., Hratchian, H. P., Cross, J. B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R. E., Yazyev, O., Austin, A. J., Cammi, R., Pomelli, C., Ochterski, J. W., Ayala, P. Y., Morokuma, K., Voth, G. A., Salvador, P., Dannenberg, J. J., Zakrzewski, V. G., Dapprich, S., Daniels, A. D., Strain, M. C., Farkas, O., Malick, D. K., Rabuck, A. D., Raghavachari, K., Foresman, J. B., Ortiz, J. V., Cui, Q., Baboul, A. G., Clifford, S., Cioslowski, J., Stefanov, B. B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Martin, R. L., Fox, D. J., Keith, T., Al-Laham, M. A., Peng, C. Y., Nanayakkara, A., Challacombe, M., Gill, P. M. W., Johnson, B., Chen, W., Wong, M. W., Gonzalez, C., and Pople, J. A. (2004) Gaussian 03, Gaussian, Inc., Wallingford, CT.
52. Hoffman, R. M. B., Li, M. X., and Sykes, B. D. (2005) The binding of W7, an inhibitor of striated muscle contraction, to cardiac troponin C Biochemistry 44, 15750-15759
53. McCoy, M. A. and Wyss, D. F. (2002) Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations J. Am. Chem. Soc. 124, 11758-11763
54. Guntert, P. (2004) Automated NMR structure calculation with CYANA Methods Mol. Biol. 278, 353-378
55. Cornilescu, G., Delaglio, F., and Bax, A. (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology J. Biomol. NMR 13, 289-302
56. Linge, J. P., Williams, M. A., Spronk, C. A. E. M., Bonvin, A. M. J. J., and Nilges, M. (2003) Refinement of protein structures in explicit solvent Proteins: Struct., Funct., Bioinf. 50, 496-506
57. Laskowski, R. A., Rullmann, J. A. C., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR J. Biomol. NMR 8, 477-486
58. Jayatilake, G. S., Jayasuriya, H., Lee, E. S., Koonchanok, N. M., Geahlen, R. L., Ashendel, C. L., Mclaughlin, J. L., and Chang, C. J. (1993) Kinase Inhibitors from Polygonum-Cuspidatum J. Nat. Prod. 56, 1805-1810
59. Koh, D., Park, K. H., Jung, J., Yang, H., Mok, K. H., and Lim, Y. (2001) Complete assignment of the H-1 and C-13 NMR spectra of resveratrol derivatives Magn. Reson. Chem. 39, 768-770
60. Commodari, F., Khiat, A., Ibrahimi, S., Brizius, A. R., and Kalkstein, N. (2005) Comparison of the phytoestrogen trans-resveratrol (3,4′,5- trihydroxystilbene) structures from X-ray diffraction and solution NMR Magn. Reson. Chem. 43, 567-572
61. Bonechi, C., Martini, S., Magnani, A., and Rossi, C. (2008) Stacking interaction study of trans-resveratrol (trans-3,5,4′-trihydroxystilbene) in solution by nuclear magnetic resonance and Fourier transform infrared spectroscopy Magn. Reson. Chem. 46, 625-629
62. Karplus, M. (1959) Contact Electron-Spin Coupling of Nuclear Magnetic Moments J. Chem. Phys. 30, 11-15
63. Trela, B. C. and Waterhouse, A. L. (1996) Resveratrol: Isomeric molar absorptivities and stability J. Agric. Food Chem. 44, 1253-1257
64. Caruso, F., Tanski, J., Villegas-Estrada, A., and Rossi, M. (2004) Structural basis for antioxidant activity of trans-resveratrol: Ab initio calculations and crystal and molecular structure J. Agric. Food Chem. 52, 7279-7285
65. Yin, Q., Shi, Y. M., Liu, H. M., Li, C. B., and Zhang, W. Q. (2002) (E)-3,5,4′-Trimethoxystilbene Acta Crystallogr. E58, O1180-O1181
66. Robertson, I. M., Pineda-Sanabria, S., and Sykes, B. D. (2011) Approaches to protein-ligand structure determination by NMR spectroscopy: Applications in drug binding to the cardiac regulatory protein troponin C Biophysics and Structure to Counter Threats and Challenges (in press)
67. Baryshnikova, O. K., Robertson, I. M., Mercier, P., and Sykes, B. D. (2008) Dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I Biochemistry 47, 10950-10960
68. Gasmi-Seabrook, G. M., Howarth, J. W., Finley, N., Abusamhadneh, E., Gaponenko, V., Brito, R. M., Solaro, R. J., and Rosevear, P. R. (1999) Solution structures of the C-terminal domain of cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I Biochemistry 38, 8313-8322
69. Lindhout, D. A. and Sykes, B. D. (2003) Structure and dynamics of the C-domain of human cardiac troponin C in complex with the inhibitory region of human cardiac troponin I J. Biol. Chem. 278, 27024-27034
70. Ferrer, J. L., Jez, J. M., Bowman, M. E., Dixon, R. A., and Noel, J. P. (1999) Structure of chalcone synthase and the molecular basis of plant polyketide biosynthesis Nat. Struct. Biol. 6, 775-784
71. Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., and Sacchettini, J. C. (2000) Rational design of potent human transthyretin amyloid disease inhibitors Nat. Struct. Biol. 7, 312-321
72. Austin, M. B., Bowman, M. E., Ferrer, J. L., Schroder, J., and Noel, J. P. (2004) An aldol switch discovered in stilbene synthases mediates cyclization specificity of type III polyketide synthases Chem. Biol. 11, 1179-1194
73. Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y. L., Hsieh, T. C., Wu, J. M., and Zhang, Z. T. (2004) Crystal structure of quinone reductase 2 in complex with resveratrol Biochemistry 43, 11417-11426
74. Shomura, Y., Torayama, I., Suh, D. Y., Xiang, T., Kita, A., Sankawa, U., and Miki, K. (2005) Crystal structure of stilbene synthase from Arachis hypogaea Proteins: Struct., Funct., Bioinf. 60, 803-806
75. Gledhill, J. R., Montgomery, M. G., Leslie, A. G. W., and Walker, J. E. (2007) Mechanism of inhibition of bovine F-1-ATPase by resveratrol and related polyphenols Proc. Natl. Acad. Sci. U.S.A. 104, 13632-13637
76. Davies, D. R., Mamat, B., Magnusson, O. T., Christensen, J., Haraldsson, M. H., Mishra, R., Pease, B., Hansen, E., Singh, J., Zembower, D., Kim, H., Kiselyov, A. S., Burgin, A. B., Gurney, M. E., and Stewart, L. J. (2009) Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography J. Med. Chem. 52, 4694-4715 [Erratum (2010) Biochemistry 53, 2330-2331]
77. Li, M. X., Robertson, I. M., and Sykes, B. D. (2008) Interaction of cardiac troponin with cardiotonic drugs: A structural perspective Biochem. Biophys. Res. Commun. 369, 88-99
78. Sorsa, T., Pollesello, P., and Solaro, R. J. (2004) The contractile apparatus as a target for drugs against heart failure: Interaction of levosimendan, a calcium sensitiser, with cardiac troponin c Mol. Cell. Biochem. 266, 87-107
79. Mirza, M., Marston, S., Willott, R., Ashley, C., Mogensen, J., McKenna, W., Robinson, P., Redwood, C., and Watkins, H. (2005) Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype J. Biol. Chem. 280, 28498-28506
80. Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ornmen, S. R., Potter, J. D., and Ackerman, M. J. (2008) Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C J. Mol. Cell. Cardiol. 45, 281-288
81. Swindle, N. and Tikunova, S. B. (2010) Hypertrophic Cardiomyopathy-Linked Mutation D145E Drastically Alters Calcium Binding by the C-Domain of Cardiac Troponin C Biochemistry 49, 4813-4820
82. 2+ binding sites of troponin C in the regulation of skeletal muscle contraction J. Biol. Chem. 271, 8381-8386
83. Agianian, B., Krzic, U., Qiu, F., Linke, W. A., Leonard, K., and Bullard, B. (2004) A troponin switch that regulates muscle contraction by stretch instead of calcium EMBO J. 23, 772-779
84. Solaro, R. J., Gambassi, G., Warshaw, D. M., Keller, M. R., Spurgeon, H. A., Beier, N., and Lakatta, E. G. (1993) Stereoselective Actions of Thiadiazinones on Canine Cardiac Myocytes and Myofilaments Circ. Res. 73, 981-990
85. Biffinger, J. C., Kim, H. W., and DiMagno, S. G. (2004) The polar hydrophobicity of fluorinated compounds ChemBioChem 5, 622-627
86. Smart, B. E. (2001) Fluorine substituent effects (on bioactivity) J. Fluorine Chem. 109, 3-11 (Pubitemid 33618184)
87. Cao, H., Pan, X. L., Li, C., Zhou, C., Deng, F. Y., and Li, T. H. (2003) Density functional theory calculations for resveratrol Bioorg. Med. Chem. Lett. 13, 1869-1871
88. Del Nero, J. and De Melo, C. P. (2003) Investigation of the excited states of resveratrol and related molecules Int. J. Quantum Chem. 95, 213-218
89. Leopoldini, M., Marino, T., Russo, N., and Toscano, M. (2004) Antioxidant properties of phenolic compounds: H-atom versus electron transfer mechanism J. Phys. Chem. A 108, 4916-4922
90. 2+ sensitizer EMD 57033 and cardiac troponin I inhibitory peptide Biochemistry 39, 8782-8790
91. Andrews, P. R., Craik, D. J., and Martin, J. L. (1984) Functional-Group Contributions to Drug Receptor Interactions J. Med. Chem. 27, 1648-1657
92. Hopkins, A. L., Groom, C. R., and Alex, A. (2004) Ligand efficiency: A useful metric for lead selection Drug Discovery Today 9, 430-431
93. Kuntz, I. D., Chen, K., Sharp, K. A., and Kollman, P. A. (1999) The maximal affinity of ligands Proc. Natl. Acad. Sci. U.S.A. 96, 9997-10002
94. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 23, 3-25
95. 2+ Sensitivity of Cardiac Myofilament J. Pharmacol. Sci. 109, 456-458